Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oriza Holdings is a Chinese venture capital and asset management firm founded in 2001. It manages CNY 30bn across various funds, acting as a fund of funds with exposure to numerous GPs and portfolio companies. Oriza focuses its investments on SMEs in technology, healthcare, AI, and new energy, across early-stage and growth-stage companies in China and Southeast Asia. Its healthcare portfolio includes investments in companies developing stem cell therapies, gene therapies, RNAi, and Antibody-Drug Conjugates for indications such as oncology, musculoskeletal disorders, and viral infections.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oriza Holdings.